IL-17-话题@MedSci - 梅斯（MedSci）

#IL-17#

68篇内容 | 3040人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1374419, encodeId=7a3213e4419e0, content=<a href='/topic/show?id=1727963861' target=_blank style='color:#2F92EE;'>#IL-17#</a>, objectTitle=Lancet:IL-17A单抗ixekizumab可有效改善X线轴向骨关节炎患者症状, objectType=article, longId=151699, objectId=f88a1516999f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f88a1516999f, replyNumber=0, likeNumber=55, createdTime=2018-10-25, rootId=0, userName=fzwish20000, userId=bcaa382, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f88a1516999f, moduleTitle=Lancet:IL-17A单抗ixekizumab可有效改善X线轴向骨关节炎患者症状, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=f88a1516999f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1374418, encodeId=44a113e4418fb, content=<a href='/topic/show?id=1727963861' target=_blank style='color:#2F92EE;'>#IL-17#</a>, objectTitle=Lilly将启动IXORA-R头对头试验：比较IL-17A单抗Taltz和IL-23单抗Tremfya治疗中度至重度斑块型银屑病患者的疗效, objectType=article, longId=148645, objectId=6dae148645a9, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=6dae148645a9, replyNumber=0, likeNumber=32, createdTime=2018-09-13, rootId=0, userName=fzwish20000, userId=bcaa382, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=6dae148645a9, moduleTitle=Lilly将启动IXORA-R头对头试验：比较IL-17A单抗Taltz和IL-23单抗Tremfya治疗中度至重度斑块型银屑病患者的疗效, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=6dae148645a9)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1374417, encodeId=0d0513e441733, content=<a href='/topic/show?id=1727963861' target=_blank style='color:#2F92EE;'>#IL-17#</a>, objectTitle=Immunity：Card14基因突变促进皮肤角质细胞对IL-17A的应答诱导银屑病发生的分子机制, objectType=article, longId=142828, objectId=2d0014282805, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=2d0014282805, replyNumber=0, likeNumber=79, createdTime=2018-07-11, rootId=0, userName=fzwish20000, userId=bcaa382, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=2d0014282805, moduleTitle=Immunity：Card14基因突变促进皮肤角质细胞对IL-17A的应答诱导银屑病发生的分子机制, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=2d0014282805)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1374416, encodeId=f4f113e4416a9, content=<a href='/topic/show?id=1727963861' target=_blank style='color:#2F92EE;'>#IL-17#</a>, objectTitle=J Ophthalmol：CYP4F2基因单核苷酸多态性和IL-17A浓度对视神经炎的影响, objectType=article, longId=138640, objectId=2b3d138640d3, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=2b3d138640d3, replyNumber=0, likeNumber=96, createdTime=2018-05-21, rootId=0, userName=fzwish20000, userId=bcaa382, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=2b3d138640d3, moduleTitle=J Ophthalmol：CYP4F2基因单核苷酸多态性和IL-17A浓度对视神经炎的影响, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=2b3d138640d3)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1374415, encodeId=c36113e441515, content=<a href='/topic/show?id=1727963861' target=_blank style='color:#2F92EE;'>#IL-17#</a>, objectTitle=Int Immunopharmacol：IL-17和IFN-γ对原代成骨细胞的作用, objectType=article, longId=132564, objectId=3097132564f5, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=3097132564f5, replyNumber=0, likeNumber=64, createdTime=2018-03-17, rootId=0, userName=fzwish20000, userId=bcaa382, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=3097132564f5, moduleTitle=Int Immunopharmacol：IL-17和IFN-γ对原代成骨细胞的作用, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=3097132564f5)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1374414, encodeId=498413e441482, content=<a href='/topic/show?id=1727963861' target=_blank style='color:#2F92EE;'>#IL-17#</a>, objectTitle=Ann Rheum Dis：bimekizumab在银屑病关节炎中的双重IL-17A和IL-17F中和, objectType=article, longId=124471, objectId=c0bc1244e185, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c0bc1244e185, replyNumber=0, likeNumber=80, createdTime=2017-12-26, rootId=0, userName=fzwish20000, userId=bcaa382, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c0bc1244e185, moduleTitle=Ann Rheum Dis：bimekizumab在银屑病关节炎中的双重IL-17A和IL-17F中和, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=c0bc1244e185)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1374413, encodeId=f0c313e44138a, content=<a href='/topic/show?id=1727963861' target=_blank style='color:#2F92EE;'>#IL-17#</a>, objectTitle=Hepatology：IL-17和TNF在NLRP3调节肝脏损伤和肝纤维化过程中的作用, objectType=article, longId=113248, objectId=cd14113248ee, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=cd14113248ee, replyNumber=0, likeNumber=67, createdTime=2017-09-21, rootId=0, userName=fzwish20000, userId=bcaa382, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=cd14113248ee, moduleTitle=Hepatology：IL-17和TNF在NLRP3调节肝脏损伤和肝纤维化过程中的作用, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=cd14113248ee)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1374412, encodeId=c0ec13e4412a3, content=<a href='/topic/show?id=1727963861' target=_blank style='color:#2F92EE;'>#IL-17#</a>, objectTitle=J Clin Periodontol：牙周炎患者关节炎的加重依赖于IL-17受体A的激活, objectType=article, longId=113040, objectId=c9d8113040d6, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c9d8113040d6, replyNumber=0, likeNumber=72, createdTime=2017-09-18, rootId=0, userName=fzwish20000, userId=bcaa382, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c9d8113040d6, moduleTitle=J Clin Periodontol：牙周炎患者关节炎的加重依赖于IL-17受体A的激活, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=c9d8113040d6)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1374411, encodeId=e57913e441185, content=<a href='/topic/show?id=1727963861' target=_blank style='color:#2F92EE;'>#IL-17#</a>, objectTitle=Clin Exp Allergy：吸烟增加哮喘患者支气管粘膜IL-17A表达！, objectType=article, longId=100704, objectId=0b94100e04a1, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=0b94100e04a1, replyNumber=0, likeNumber=71, createdTime=2017-06-06, rootId=0, userName=fzwish20000, userId=bcaa382, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=0b94100e04a1, moduleTitle=Clin Exp Allergy：吸烟增加哮喘患者支气管粘膜IL-17A表达！, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=0b94100e04a1)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1374410, encodeId=121613e4410b4, content=<a href='/topic/show?id=1727963861' target=_blank style='color:#2F92EE;'>#IL-17#</a>, objectTitle=EMBO Rep：浙江大学王晓健研究组揭示IL-17信号调控新机制, objectType=article, longId=100339, objectId=4c5310033999, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=4c5310033999, replyNumber=0, likeNumber=130, createdTime=2017-06-02, rootId=0, userName=fzwish20000, userId=bcaa382, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=4c5310033999, moduleTitle=EMBO Rep：浙江大学王晓健研究组揭示IL-17信号调控新机制, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=4c5310033999)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1374409, encodeId=1e7113e440987, content=<a href='/topic/show?id=1727963861' target=_blank style='color:#2F92EE;'>#IL-17#</a>, objectTitle=J Clin Endocrinol Metab：上海巴斯德所等揭示炎性因子IL-17A调控甲状腺相关眼病发生发展新机制, objectType=article, longId=97382, objectId=794d9e3823e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=794d9e3823e, replyNumber=0, likeNumber=62, createdTime=2017-04-29, rootId=0, userName=fzwish20000, userId=bcaa382, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=794d9e3823e, moduleTitle=J Clin Endocrinol Metab：上海巴斯德所等揭示炎性因子IL-17A调控甲状腺相关眼病发生发展新机制, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=794d9e3823e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1374408, encodeId=340113e44084f, content=<a href='/topic/show?id=1727963861' target=_blank style='color:#2F92EE;'>#IL-17#</a>, objectTitle=CLIN CANCER RES：产IL-17的中性粒细胞可加速胃癌进展, objectType=article, longId=92990, objectId=0c4f9299070, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=0c4f9299070, replyNumber=0, likeNumber=76, createdTime=2017-03-24, rootId=0, userName=fzwish20000, userId=bcaa382, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=0c4f9299070, moduleTitle=CLIN CANCER RES：产IL-17的中性粒细胞可加速胃癌进展, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=0c4f9299070)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1374407, encodeId=f47f13e440719, content=<a href='/topic/show?id=1727963861' target=_blank style='color:#2F92EE;'>#IL-17#</a>, objectTitle=Nat Immunol：itch抑制IL-17介导的肠炎机制, objectType=article, longId=73155, objectId=1ef6e31556c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=1ef6e31556c, replyNumber=0, likeNumber=70, createdTime=2016-07-20, rootId=0, userName=fzwish20000, userId=bcaa382, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=1ef6e31556c, moduleTitle=Nat Immunol：itch抑制IL-17介导的肠炎机制, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=1ef6e31556c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1374406, encodeId=531413e44062d, content=<a href='/topic/show?id=1727963861' target=_blank style='color:#2F92EE;'>#IL-17#</a>, objectTitle=Immunity：OX-40调控IL-17分化机制, objectType=article, longId=71591, objectId=75cde1591d9, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=75cde1591d9, replyNumber=0, likeNumber=56, createdTime=2016-06-26, rootId=0, userName=fzwish20000, userId=bcaa382, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=75cde1591d9, moduleTitle=Immunity：OX-40调控IL-17分化机制, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=75cde1591d9)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1374405, encodeId=b7a513e4405d7, content=<a href='/topic/show?id=1727963861' target=_blank style='color:#2F92EE;'>#IL-17#</a>, objectTitle=IL-12和IL-17强直性脊柱炎患者的外周血表达水平及两者之间相关性研究, objectType=article, longId=66250, objectId=8ae56625061, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=8ae56625061, replyNumber=0, likeNumber=62, createdTime=2016-04-10, rootId=0, userName=fzwish20000, userId=bcaa382, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=8ae56625061, moduleTitle=IL-12和IL-17强直性脊柱炎患者的外周血表达水平及两者之间相关性研究, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=8ae56625061)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1374404, encodeId=e23313e440440, content=<a href='/topic/show?id=1727963861' target=_blank style='color:#2F92EE;'>#IL-17#</a>, objectTitle=Stem Cells：经IL-17处理的干细胞可能控制移植病人的排斥反应, objectType=article, longId=52897, objectId=59365289ea8, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=59365289ea8, replyNumber=0, likeNumber=60, createdTime=2015-07-07, rootId=0, userName=fzwish20000, userId=bcaa382, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=59365289ea8, moduleTitle=Stem Cells：经IL-17处理的干细胞可能控制移植病人的排斥反应, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=59365289ea8)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1374403, encodeId=933313e44038e, content=<a href='/topic/show?id=1727963861' target=_blank style='color:#2F92EE;'>#IL-17#</a>, objectTitle=The Lancet：单抗药物ixekizumab中和白介素IL-17A 成功治疗银屑病, objectType=article, longId=52031, objectId=a0e8520314d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a0e8520314d, replyNumber=0, likeNumber=63, createdTime=2015-06-14, rootId=0, userName=fzwish20000, userId=bcaa382, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a0e8520314d, moduleTitle=The Lancet：单抗药物ixekizumab中和白介素IL-17A 成功治疗银屑病, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=a0e8520314d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1374402, encodeId=f55813e4402a5, content=<a href='/topic/show?id=1727963861' target=_blank style='color:#2F92EE;'>#IL-17#</a>, objectTitle=礼来IL-17A单抗ixekizumab银屑病关节炎III期成功, objectType=article, longId=49722, objectId=d82a49e227a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d82a49e227a, replyNumber=0, likeNumber=38, createdTime=2015-04-24, rootId=0, userName=fzwish20000, userId=bcaa382, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d82a49e227a, moduleTitle=礼来IL-17A单抗ixekizumab银屑病关节炎III期成功, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=d82a49e227a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1374401, encodeId=0e0b13e440150, content=<a href='/topic/show?id=1727963861' target=_blank style='color:#2F92EE;'>#IL-17#</a>, objectTitle=诺华单抗Cosentyx将于2015年初上市，将成为IL-17阻断剂, objectType=article, longId=43163, objectId=6a714316374, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=6a714316374, replyNumber=0, likeNumber=127, createdTime=2014-11-28, rootId=0, userName=fzwish20000, userId=bcaa382, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=6a714316374, moduleTitle=诺华单抗Cosentyx将于2015年初上市，将成为IL-17阻断剂, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=6a714316374)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1374400, encodeId=d0e213e4400b8, content=<a href='/topic/show?id=1727963861' target=_blank style='color:#2F92EE;'>#IL-17#</a>, objectTitle=牛皮癣新药IL-17受体单抗brodalumab三期研究获得成功, objectType=article, longId=34817, objectId=57b53481e9f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=57b53481e9f, replyNumber=0, likeNumber=102, createdTime=2014-05-17, rootId=0, userName=fzwish20000, userId=bcaa382, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=57b53481e9f, moduleTitle=牛皮癣新药IL-17受体单抗brodalumab三期研究获得成功, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=57b53481e9f)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

IL-17

2020-05-29

fzwish20000 (审核中...)

前往app查看评论内容

#IL-17#

Lancet:IL-17A单抗ixekizumab可有效改善X线轴向骨关节炎患者症状

2018-10-25

fzwish20000 (审核中...)

前往app查看评论内容

#IL-17#

Lilly将启动IXORA-R头对头试验：比较IL-17A单抗Taltz和IL-23单抗Tremfya治疗中度至重度斑块型银屑病患者的疗效

2018-09-13

fzwish20000 (审核中...)

前往app查看评论内容

#IL-17#

Immunity：Card14基因突变促进皮肤角质细胞对IL-17A的应答诱导银屑病发生的分子机制

2018-07-11

fzwish20000 (审核中...)

前往app查看评论内容

#IL-17#

J Ophthalmol：CYP4F2基因单核苷酸多态性和IL-17A浓度对视神经炎的影响

2018-05-21

fzwish20000 (审核中...)

前往app查看评论内容

#IL-17#

Int Immunopharmacol：IL-17和IFN-γ对原代成骨细胞的作用

2018-03-17

fzwish20000 (审核中...)

前往app查看评论内容

#IL-17#

Ann Rheum Dis：bimekizumab在银屑病关节炎中的双重IL-17A和IL-17F中和

2017-12-26

fzwish20000 (审核中...)

前往app查看评论内容

#IL-17#

Hepatology：IL-17和TNF在NLRP3调节肝脏损伤和肝纤维化过程中的作用

2017-09-21

fzwish20000 (审核中...)

前往app查看评论内容

#IL-17#

J Clin Periodontol：牙周炎患者关节炎的加重依赖于IL-17受体A的激活

2017-09-18

fzwish20000 (审核中...)

前往app查看评论内容

#IL-17#

Clin Exp Allergy：吸烟增加哮喘患者支气管粘膜IL-17A表达！

2017-06-06

fzwish20000 (审核中...)

前往app查看评论内容

#IL-17#

EMBO Rep：浙江大学王晓健研究组揭示IL-17信号调控新机制

2017-06-02

fzwish20000 (审核中...)

前往app查看评论内容

#IL-17#

J Clin Endocrinol Metab：上海巴斯德所等揭示炎性因子IL-17A调控甲状腺相关眼病发生发展新机制

2017-04-29

fzwish20000 (审核中...)

前往app查看评论内容

#IL-17#

CLIN CANCER RES：产IL-17的中性粒细胞可加速胃癌进展

2017-03-24

fzwish20000 (审核中...)

前往app查看评论内容

#IL-17#

Nat Immunol：itch抑制IL-17介导的肠炎机制

2016-07-20

fzwish20000 (审核中...)

前往app查看评论内容

#IL-17#

Immunity：OX-40调控IL-17分化机制

2016-06-26

fzwish20000 (审核中...)

前往app查看评论内容

#IL-17#

IL-12和IL-17强直性脊柱炎患者的外周血表达水平及两者之间相关性研究

2016-04-10

fzwish20000 (审核中...)

前往app查看评论内容

#IL-17#

Stem Cells：经IL-17处理的干细胞可能控制移植病人的排斥反应

2015-07-07

fzwish20000 (审核中...)

前往app查看评论内容

#IL-17#

The Lancet：单抗药物ixekizumab中和白介素IL-17A 成功治疗银屑病

2015-06-14

fzwish20000 (审核中...)

前往app查看评论内容

#IL-17#

礼来IL-17A单抗ixekizumab银屑病关节炎III期成功

2015-04-24

fzwish20000 (审核中...)

前往app查看评论内容

#IL-17#

诺华单抗Cosentyx将于2015年初上市，将成为IL-17阻断剂

2014-11-28

fzwish20000 (审核中...)

前往app查看评论内容

#IL-17#

牛皮癣新药IL-17受体单抗brodalumab三期研究获得成功

2014-05-17

科室
- - 订阅+
  - 更多科室
工具
服务